Dr Frank Reimann
Frank Reimann is currently a Reader at the University of Cambridge and a Principal Investigator at the Wellcome Trust/MRC Institute of Metabolic Science (IMS) at Addenbrooke’s Hospital (http://www.mrl.ims.cam.ac.uk/). After studying biochemistry in Hannover and receiving a PhD for work with cloned potassium channels in Hamburg in 1997, he moved to Oxford and subsequently in 2000 to Cambridge. His group, run in collaboration with Fiona Gribble, investigates the stimulus secretion coupling of enteroendocrine cells using approaches combining molecular biological, electrophysiological and fluorescent imaging techniques. The lab has mainly focused on the incretin hormones glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1), but has also created models to study release of somatostatin and insulin-like peptide-5. Other interests include the role of voltage gated ion channels in nociception.